Genenta Science S.p.A. - American Depositary Shares (GNTA)
GNTA moved a median of -0.20% 30 minutes after news, and -1.50% by the close. How GNTA actually reacts to news — the realized, point-in-time move the market made, measured across 97 labeled events over the last three years with zero look-ahead.
GNTA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 26% | 82 |
| 30-min | -0.20% | 38% | 89 |
| 60-min | -0.79% | 34% | 90 |
| to close | -1.50% | 39% | 93 |
| Middle 50% of GNTA reactions | -3.83% to +1.15% |
|---|---|
| Median reaction (30-min) | -0.20% |
| Measured reactions | 97 |
Half of all Genenta Science S.p.A. - American Depositary Shares news events land between -3.83% and +1.15% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when GNTA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GNTA's baseline. Nothing else.
Recent GNTA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K Genenta Science S.p.A. For: Oct 13 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -6.36% | |
| Form 6-K Genenta Science S.p.A. For: Oct 07 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -5.33% | |
| Sòphia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit | Press release | GlobeNewswire | +1.50% | +0.18% | |
| Form 6-K Genenta Science S.p.A. For: Sep 11 | SEC filing · Form 6-K | SEC EDGAR | +1.22% | +1.39% | |
| Form 6-K Genenta Science S.p.A. For: Sep 01 | SEC filing · Form 6-K | SEC EDGAR | — | -3.16% | |
| Form 6-K Genenta Science S.p.A. For: Jul 31 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -8.44% | |
| Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm | Press release | GlobeNewswire | -1.24% | +2.48% | |
| Genenta-Backed Sòphia High Tech Reports Fiscal Year 2025 Results | Press release | GlobeNewswire | +0.61% | -0.61% | |
| Form 6-K Genenta Science S.p.A. For: Jul 14 | SEC filing · Form 6-K | SEC EDGAR | +7.80% | +6.38% | |
| Form 6-K Genenta Science S.p.A. For: Jul 01 | SEC filing · Form 6-K | SEC EDGAR | +0.06% | -3.37% | |
| Form 6-K Genenta Science S.p.A. For: Jun 26 | SEC filing · Form 6-K | SEC EDGAR | -3.33% | -7.69% | |
| Form 6-K Genenta Science S.p.A. For: Jun 24 | SEC filing · Form 6-K | SEC EDGAR | -2.15% | -0.54% | |
| Form 6-K Genenta Science S.p.A. For: Jun 17 | SEC filing · Form 6-K | SEC EDGAR | -5.32% | -2.13% | |
| Form 6-K Genenta Science S.p.A. For: Jun 16 | SEC filing · Form 6-K | SEC EDGAR | -5.11% | +6.25% | |
| Developmental and Epileptic Encephalopathies Market to Register Immense Growth at a CAGR of 11.7% During the Forecast Period (2026-2036) Due to the Launch of Next-Generation Gene and Targeted Therapies | DelveInsight | Press release | PR Newswire | -0.75% | +16.97% | |
| Form 6-K Genenta Science S.p.A. For: May 29 | SEC filing · Form 6-K | SEC EDGAR | +20.33% | -9.34% | |
| Form 6-K Genenta Science S.p.A. For: May 19 | SEC filing · Form 6-K | SEC EDGAR | +4.26% | +4.11% | |
| Form 6-K Genenta Science S.p.A. For: Apr 28 | SEC filing · Form 6-K | SEC EDGAR | +0.01% | +1.10% | |
| Form 6-K Genenta Science S.p.A. For: Apr 23 | SEC filing · Form 6-K | SEC EDGAR | -0.53% | +0.45% | |
| Genenta signs Definitive Agreements with Sophia High Tech | Press release | GlobeNewswire | +1.00% | -0.99% | |
| Form 6-K Genenta Science S.p.A. For: Apr 14 | SEC filing · Form 6-K | SEC EDGAR | — | +8.11% | |
| Form 20-F Genenta Science S.p.A. For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | -1.88% | +2.52% | |
| Form 6-K Genenta Science S.p.A. For: Mar 27 | SEC filing · Form 6-K | SEC EDGAR | +3.16% | -17.61% | |
| Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs | Press release | GlobeNewswire | +3.16% | -17.61% | |
| Form 6-K Genenta Science S.p.A. For: Mar 23 | SEC filing · Form 6-K | SEC EDGAR | +1.63% | +9.09% | |
| Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini | Press release | GlobeNewswire | +1.63% | +9.09% | |
| Genenta, Evolving into Saentra Forge, Announces CEO’s Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University | Press release | GlobeNewswire | +0.00% | +4.14% | |
| Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform | Press release | GlobeNewswire | -0.79% | +0.43% | |
| Form 6-K Genenta Science S.p.A. For: Jan 27 | SEC filing · Form 6-K | SEC EDGAR | -10.44% | -9.41% | |
| Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator | Press release | GlobeNewswire | -10.44% | -9.41% | |
| Italy on the Move Brings 200+ Italy-US Biotech, Pharma and Investment Leaders Together in San Francisco During JPM Week | Press release | PR Newswire | -4.93% | -2.88% | |
| Genenta Science Provides Update on CEO Ownership | Press release | GlobeNewswire | -3.31% | -12.65% | |
| Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial | Press release | GlobeNewswire | -4.35% | -3.26% | |
| Form 6-K Genenta Science S.p.A. For: Oct 31 | SEC filing · Form 6-K | SEC EDGAR | -3.45% | -11.88% | |
| Form 6-K Genenta Science S.p.A. For: Oct 28 | SEC filing · Form 6-K | SEC EDGAR | -1.77% | -29.20% | |
| Form 6-K Genenta Science S.p.A. For: Oct 27 | SEC filing · Form 6-K | SEC EDGAR | -5.25% | -17.00% | |
| Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares | Press release | GlobeNewswire | -5.25% | -17.00% | |
| Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production | Press release | GlobeNewswire | -13.77% | -37.25% | |
| Form 6-K Genenta Science S.p.A. For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +0.65% | +13.03% | |
| Form 6-K Genenta Science S.p.A. For: Oct 03 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +5.57% | |
| Form 6-K Genenta Science S.p.A. For: Sep 10 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -21.43% | |
| Form 6-K Genenta Science S.p.A. For: Aug 01 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -3.65% | |
| Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals | Press release | GlobeNewswire | -1.75% | +33.57% | |
| Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies | Press release | GlobeNewswire | — | -3.35% | |
| EPIDIOLEX Continues to Lead the Way in Cannabinoid-Based Epilepsy Treatment | DelveInsight | Press release | PR Newswire | — | — | |
| Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar | Press release | GlobeNewswire | -4.74% | +0.75% | |
| Form 20-F Genenta Science S.p.A. For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | +0.00% | -2.46% | |
| Form 6-K Genenta Science S.p.A. For: Mar 19 | SEC filing · Form 6-K | SEC EDGAR | -6.58% | -3.36% | |
| Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates | Press release | GlobeNewswire | -6.58% | -3.36% | |
| TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE | Press release | PR Newswire | +0.00% | +2.25% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GNTA section they belong to.
Where else GNTA is measured.
GNTA earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Genenta Science S.p.A. - American Depositary Shares's median reaction calculated?
Every labeled GNTA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 97 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 38% of GNTA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does GNTA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.